Suppr超能文献

奈福泮在加速储存条件下溶液中的降解机制。

Degradation mechanism of nefopam in solution under stressed storage conditions.

作者信息

Wang D P, Tu Y H, Allen L V, Cheng F C

机构信息

National Defense Medical Center, College of Pharmacy, Taipei, Taiwan, R.O.C.

出版信息

Acta Pharm Nord. 1990;2(2):73-82.

PMID:2354032
Abstract

Nefopam, in pH 2.0 and pH 9.0 solutions, was forcibly degraded at 90 +/- 0.2 degrees C for 60 days. At least eight degradation products from the above solutions were collected from a reverse-phase high performance liquid chromatographic (HPLC) system with a C18 semipreparative column. Some minor peaks were considered insignificant, and no attempt was made to collect and identify their structures. The collected eluents under each major peak were further purified by extraction with methylene chloride from alkaline solutions. Proton nuclear magnetic resonance and fast atom bombardment mass spectroscopy were used to characterize the chemical properties of these degradates. The chemical structures of the major degradation products were proposed as (B) or (C) 2,3-dihydro-2(2'-hydroxyethyl)-N-methyl-1-phenyl-isoindole; (D) or (E) 1-hydroxy-3,4,5,6-tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine++ +; (F) 2-(N-(2-hydroxyethyl)-N-methylaminomethyl) benzhydrol; (G) 2-(N-(2-hydroxyethyl)-N-methylaminoethyl) benzophenone; (H) 1-hydroxy-3,4,5,6-tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine++ +, where B and C, D and E, are diasteromers. The possible pathways by which the nefopam degradation proceeded in acidic and basic solutions is postulated as Schemes I and II, respectively. The initial ring-opening process at the site of ether linkage appears to be the rate-determining step of degradation in both acidic and basic solutions.

摘要

奈福泮在pH 2.0和pH 9.0的溶液中,于90±0.2℃强制降解60天。使用C18半制备柱的反相高效液相色谱(HPLC)系统从上述溶液中收集了至少八种降解产物。一些小峰被认为不显著,未尝试收集并鉴定其结构。每个主峰下收集的洗脱液通过从碱性溶液中用二氯甲烷萃取进一步纯化。使用质子核磁共振和快原子轰击质谱对这些降解产物的化学性质进行表征。主要降解产物的化学结构被推测为(B)或(C)2,3-二氢-2(2'-羟乙基)-N-甲基-1-苯基异吲哚;(D)或(E)1-羟基-3,4,5,6-四氢-5-甲基-1-苯基-1H-2,5-苯并恶唑嗪;(F)2-(N-(2-羟乙基)-N-甲基氨基甲基)二苯甲醇;(G)2-(N-(2-羟乙基)-N-甲基氨基乙基)二苯甲酮;(H)1-羟基-3,4,5,6-四氢-5-甲基-1-苯基-1H-2,5-苯并恶唑嗪,其中B和C、D和E为非对映异构体。奈福泮在酸性和碱性溶液中降解的可能途径分别假定为方案I和方案II。醚键位点的初始开环过程似乎是酸性和碱性溶液中降解的速率决定步骤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验